| E-Folder |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > A Guide to Mergers and Acquisitions |
|
E-Folder - A Guide to Mergers and Acquisitions
Mergers and acquisitions are common terms used to refer to the amalgamation of companies. A merger results when According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product two companies come together to form a single company. Mergers are similar to acquisitions, excluding that in m ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in rgers, existing stockholders of both companies maintain a shared interest in the new enlarged entity. The share lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. olding pattern may vary, depending on the valuation of companies concerned. When one company buys out the cont here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe olling or considerable portion of another company's stock, it is termed as acquisitions. The buyer company take d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro over the other company. It creates an uneven balance of ownership. No new company is formed in case of acquisi ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ions. Mergers and acquisitions may be undertaken for several reasons, some of which are advantageous to shareh easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi lders while some are not. At times, such deals may be undertaken to save on taxes. The accumulated losses of th nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically target company could be set off against profits of the company that is taking over, resulting in significant t and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ x savings. Another reason for a merger or acquisitions is that such deals often help to expand the market shar ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi . Most large corporations use this strategy to improve business. Mergers and acquisitions may also be undertake ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a to combine two companies that make different, but complementary, products. Plans and negotiations for mergers dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod and acquisitions are generally kept confidential until the deal is almost finalized. Generally, investment bank cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin rs, consultants and lawyers specializing in this field, process such deals. Frequently, the services of another tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen type of specialists known as 'interim managers' may be utilized also, to smooth out the process. All mergers a t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel d acquisitions are believed to be done for the benefit of the stockholders of both companies. Actually this may ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust not be always true. Those who have stocks are advised to cautiously study proposals for mergers and acquisition y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products before accepting the deal. Merger and acquisition processes will undoubtedly change in the near future, as dy . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de amic technologies permit for development of a more efficient marketplace. This manages to protect the privacy o elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip companies involved in the deal and at the same time linking up perfect candidates for mergers and acquisitions tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Go Freelance But Don't Make This Mistake Buying Gold as a Form of Investment Should You Start A Business With A Friend?
|